Tesamorelin / Ipamorelin Blend
This pre-blended formulation combines Tesamorelin (11mg) with Ipamorelin (3mg), pairing the longest-acting clinically-validated GHRH analogue with the most selective ghrelin-receptor agonist. The combination models simultaneous activation of both arms of growth hormone secretion in a research vial — Tesamorelin sustaining baseline GHRH-receptor tone and Ipamorelin generating selective pulse-like GHS-receptor signaling.
Research Areas
- •Dual GH pathway
- •Visceral adipose tissue
- •Body composition
- •Recovery protocols
Molecular Specifications
Molecular Formula
Blend
Molecular Weight
Blend
Purity
≥98.0% (each)
Select Size
Prices are subject to change. Final pricing will be confirmed at checkout.
Certificates of Analysis
Current batch test results for Tesamorelin / Ipamorelin Blend. Click any row to download the full lab report PDF — third-party HPLC, USP<85> endotoxin, and USP<71> microbial testing.
| Size | Batch | Test Date | Purity | Endotox | Sterility | |
|---|---|---|---|---|---|---|
| 14mg | PC-G2-TIPA | 04/22/2026 | blend | Pass | Pass | View PDF |
You May Also Like
CJC-1295 No DAC (Mod GRF 1-29)
Short-acting GHRH analogue (Modified GRF 1-29) for growth hormone research.
From $51.99
View DetailsCJC-1295 No DAC / Ipamorelin Blend
Classic GH-stacking blend — Mod GRF 1-29 + Ipamorelin in a single vial.
From $64.99
View DetailsPT-141 (Bremelanotide)
Melanocortin receptor agonist for research applications.
From $61.99
View Details